Noble Roman's, Inc.
NROM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $15,150 | $14,374 | $14,453 | $13,885 |
| % Growth | 5.4% | -0.5% | 4.1% | – |
| Cost of Goods Sold | $10,498 | $8,837 | $11,407 | $9,502 |
| Gross Profit | $4,652 | $5,536 | $3,046 | $4,383 |
| % Margin | 30.7% | 38.5% | 21.1% | 31.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2,642 | $1,549 | $2,168 | $1,791 |
| SG&A Expenses | $2,642 | $1,549 | $2,168 | $1,791 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $535 | $0 | $451 | $849 |
| Operating Expenses | $3,177 | $2,096 | $2,618 | $2,640 |
| Operating Income | $1,475 | $3,440 | $428 | $1,744 |
| % Margin | 9.7% | 23.9% | 3% | 12.6% |
| Other Income/Exp. Net | -$1,636 | -$1,979 | -$1,884 | -$1,362 |
| Pre-Tax Income | -$161 | $1,460 | -$1,199 | $382 |
| Tax Expense | -$157 | $0 | -$142 | -$128 |
| Net Income | -$3 | $1,460 | -$1,056 | $509 |
| % Margin | -0% | 10.2% | -7.3% | 3.7% |
| EPS | -0 | 0.068 | -0.05 | 0.02 |
| % Growth | -100.1% | 236.6% | -350% | – |
| EPS Diluted | -0 | 0.064 | -0.048 | 0.02 |
| Weighted Avg Shares Out | 22,216 | 22,216 | 21,121 | 23,642 |
| Weighted Avg Shares Out Dil | 24,310 | 23,600 | 22,216 | 23,642 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,637 | $1,744 | $1,884 | $1,362 |
| Depreciation & Amortization | $500 | $380 | $943 | $1,330 |
| EBITDA | $1,977 | $3,584 | $1,371 | $3,074 |
| % Margin | 13% | 24.9% | 9.5% | 22.1% |